STVN
Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$18.28
+0.27% today
Updated 2026-05-11
Market cap
$4.99B
P/E ratio
30.47
P/S ratio
4.15x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$13 – $28
Volume
0.6M
Stevanato Group SpA (STVN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $781.58M | $882.18M | $967.98M | $1.42B | $1.66B | $2.07B | $2.33B |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $394.88M | $449.58M | $492.77M | $865.97M | $845.77M | $861.89M | $880.12M |
| Total liabilities | $550.18M | $616.74M | $657.84M | $577.18M | $663.79M | $938.93M | $924.43M |
| Current liabilities | $243.91M | $262.94M | $316.18M | $338.62M | $462.50M | $574.39M | $477.47M |
| Long-term debt | $245.19M | $284.18M | $273.94M | $183.99M | $133.75M | $242.05M | $305.23M |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | — | $287.33M | $355.61M | $27.00M | $623.35M | $757.86M | $863.44M |
| Accounts receivable | $181.04M | $160.58M | $167.25M | $278.42M | $369.48M | $522.48M | $529.87M |
| Inventory | $98.61M | $131.88M | $139.37M | $148.92M | $213.25M | $255.32M | $245.22M |
| Goodwill | $47.24M | $47.24M | $47.24M | $47.24M | $47.24M | $49.98M | $49.98M |